U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs

U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs

Source: 
Reuters
snippet: 

The U.S. Federal Trade Commission said on Friday it would require Impax Laboratories Inc and privately held Amneal Pharmaceuticals LLC to divest rights to 10 generic medications as a condition of their merger.